The efficacy and safety of convalescent plasma for COVID-19 patients: a meta-analysis based on double-blinded parallel-arm randomized placebo-controlled trials.
Saved in:
| Title: | The efficacy and safety of convalescent plasma for COVID-19 patients: a meta-analysis based on double-blinded parallel-arm randomized placebo-controlled trials. |
|---|---|
| Authors: | Du R; Institute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100020, PR China., Yang J; Office for Cancer Diagnosis and Treatment Quality Control, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Yang W; Office for Cancer Diagnosis and Treatment Quality Control, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. wenjing86824@126.com., Liao P; Department of Paediatrics, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China. tzliaopy@163.com. |
| Source: | BMC infectious diseases [BMC Infect Dis] 2026 Jan 26; Vol. 26 (1), pp. 147. Date of Electronic Publication: 2026 Jan 26. |
| Publication Type: | Journal Article; Meta-Analysis |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1471-2334 |
|---|---|
| DOI: | 10.1186/s12879-025-12126-4 |
